# Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC

> **NCT04221347** · — · UNKNOWN · sponsor: **Military University Hospital, Prague** · enrollment: 250 (estimated)

## Conditions studied

- Liver Cancer
- Hepatocellular Carcinoma
- Cirrhosis, Liver

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT04221347
- **Lead sponsor:** Military University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221347, "Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04221347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*